SCHEMBL9203094

SCHEMBL9203094

NCCC[C@H](NC(=O)Cc1ccc(O)cc1)C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CHRND Q07001 10/20 0.54
▸ CHRNA1 P02708 6/20 0.54
▸ CHRNG P07510 6/20 0.54
▸ CHRNB1 P11230 6/20 0.54
▸ GRIA1 P42261 4/20 0.51
▸ PTPN2 P17706 1/20 0.48
▸ PTPN1 P18031 1/20 0.48
▸ HPGDS O60760 1/20 0.48
▸ CA2 P00918 1/20 0.45
▸ ITGB3 P05106 1/20 0.44
▸ ITGA2B P08514 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203772 0.87 ITGB3 (0.54) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL9277061 0.85 HTT (0.54) CA2ITGB3ITGA2B
SCHEMBL9195867 0.82 IDE (0.52) ITGB3ITGA2B
SCHEMBL8528256 0.78 CHRND (0.45) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL8524876 0.77 ITGB3 (0.62) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL8524877 0.77 ITGB3 (0.62) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL29868753 0.76 LNPEP (0.55) —
SCHEMBL16728259 0.76 CHRND (0.46) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL15186016 0.75 CHRND (0.62) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL8269341 0.75 ITGB3 (0.46) CHRNDCHRNA1CHRNGCHRNB1GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0680469-A1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME Dr. Karl Thomae GmbH (DE) 1995-11-08 — — EP disclosed
WO-1994017035-A1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME DR. KARL THOMAE GMBH (DE) 1994-08-04 — — WO disclosed
Send feedback